BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 31750595)

  • 1. The risk of second primary tumors in head and neck cancer: A systematic review.
    Coca-Pelaz A; Rodrigo JP; Suárez C; Nixon IJ; Mäkitie A; Sanabria A; Quer M; Strojan P; Bradford CR; Kowalski LP; Shaha AR; de Bree R; Hartl DM; Rinaldo A; Takes RP; Ferlito A
    Head Neck; 2020 Mar; 42(3):456-466. PubMed ID: 31750595
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence of second metachronous head and neck cancers: population-based outcomes over 25 years.
    Tiwana MS; Hay J; Wu J; Wong F; Cheung W; Olson RA
    Laryngoscope; 2014 Oct; 124(10):2287-91. PubMed ID: 24729185
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endoscopic screening of the upper gastrointestinal tract for second primary tumors in patients with head and neck cancer in a Western country.
    van Tilburg L; van de Ven SEM; de Jonge PJF; de Graaf W; Spaander MCW; Nikkessen S; Hardillo JA; Sewnaik A; Monserez DA; Mast H; Keereweer S; Bruno MJ; Baatenburg de Jong RJ; Koch AD
    Endoscopy; 2023 Nov; 55(11):981-990. PubMed ID: 37328150
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic impact of second primary tumors in head and neck cancer.
    Patrucco MS; Aramendi MV
    Eur Arch Otorhinolaryngol; 2016 Jul; 273(7):1871-7. PubMed ID: 26119843
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of smoking status, disease stage, and index tumor site on second primary tumor incidence and tumor recurrence in the head and neck retinoid chemoprevention trial.
    Khuri FR; Kim ES; Lee JJ; Winn RJ; Benner SE; Lippman SM; Fu KK; Cooper JS; Vokes EE; Chamberlain RM; Williams B; Pajak TF; Goepfert H; Hong WK
    Cancer Epidemiol Biomarkers Prev; 2001 Aug; 10(8):823-9. PubMed ID: 11489748
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of age at diagnosis of head and neck cancer on incidence of metachronous cancer.
    Iwatsubo T; Ishihara R; Morishima T; Maekawa A; Nakagawa K; Arao M; Ohmori M; Iwagami H; Matsuno K; Inoue S; Nakahira H; Matsuura N; Shichijo S; Kanesaka T; Yamamoto S; Takeuchi Y; Higashino K; Uedo N; Miyashiro I; Higuchi K; Fujii T
    BMC Cancer; 2019 Jan; 19(1):3. PubMed ID: 30606157
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment Modality and Second Primary Tumors of the Head and Neck.
    Ben Arie G; Shafat T; Belochitski O; El-Saied S; Joshua BZ
    ORL J Otorhinolaryngol Relat Spec; 2021; 83(6):420-427. PubMed ID: 34587611
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnosis of second head and neck tumors in primary laryngeal SCC is an indicator of overall survival and not associated with poorer overall survival: a single centre study in 987 patients.
    Farhadieh RD; Salardini A; Yang JL; Russell P; Smee R
    J Surg Oncol; 2010 Jan; 101(1):72-7. PubMed ID: 19798688
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Impact of Smoking Cessation and Continuation on Recurrence and Survival in Patients with Head and Neck Cancer: A Systematic Review of the Literature.
    von Kroge PR; Bokemeyer F; Ghandili S; Bokemeyer C; Seidel C
    Oncol Res Treat; 2020; 43(10):549-558. PubMed ID: 32950990
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk Factors Linking Esophageal Squamous Cell Carcinoma With Head and Neck Cancer or Gastric Cancer.
    Onochi K; Shiga H; Takahashi S; Watanabe N; Fukuda S; Ishioka M; Koizumi S; Matsuhasi T; Jin M; Iijima K
    J Clin Gastroenterol; 2019 Apr; 53(4):e164-e170. PubMed ID: 29498952
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synchronous and metachronous head and neck carcinomas.
    Schwartz LH; Ozsahin M; Zhang GN; Touboul E; De Vataire F; Andolenko P; Lacau-Saint-Guily J; Laugier A; Schlienger M
    Cancer; 1994 Oct; 74(7):1933-8. PubMed ID: 8082099
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Head and neck cancer arising after endoscopic mucosal resection for squamous cell carcinoma of the esophagus.
    Shimizu Y; Tsukagoshi H; Fujita M; Hosokawa M; Watanabe A; Kawabori S; Kato M; Sugiyama T; Asaka M
    Endoscopy; 2003 Apr; 35(4):322-6. PubMed ID: 12664389
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk of second primary cancer in patients with head and neck squamous cell carcinoma: a systemic review and meta-analysis.
    Lu D; Zhou X; Sun H; Zeng B; Fu J; Gong J; Liao G; Liang Y; Yang L
    Clin Oral Investig; 2023 Sep; 27(9):4897-4910. PubMed ID: 37540282
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metachronous Second Primary Malignancies after Head and Neck Cancer in a Korean Cohort (1993-2010).
    Jung YS; Lim J; Jung KW; Ryu J; Won YJ
    PLoS One; 2015; 10(7):e0134160. PubMed ID: 26218068
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of multiple Lugol-voiding lesions with synchronous and metachronous esophageal squamous cell carcinoma in patients with head and neck cancer.
    Muto M; Hironaka S; Nakane M; Boku N; Ohtsu A; Yoshida S
    Gastrointest Endosc; 2002 Oct; 56(4):517-21. PubMed ID: 12297767
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early detection of esophageal second primary tumors using Lugol chromoendoscopy in patients with head and neck cancer: A systematic review and meta-analysis.
    Bugter O; van de Ven SEM; Hardillo JA; Bruno MJ; Koch AD; Baatenburg de Jong RJ
    Head Neck; 2019 Apr; 41(4):1122-1130. PubMed ID: 30593712
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alcohol Consumption and Multiple Dysplastic Lesions Increase Risk of Squamous Cell Carcinoma in the Esophagus, Head, and Neck.
    Katada C; Yokoyama T; Yano T; Kaneko K; Oda I; Shimizu Y; Doyama H; Koike T; Takizawa K; Hirao M; Okada H; Yoshii T; Konishi K; Yamanouchi T; Tsuda T; Omori T; Kobayashi N; Shimoda T; Ochiai A; Amanuma Y; Ohashi S; Matsuda T; Ishikawa H; Yokoyama A; Muto M
    Gastroenterology; 2016 Nov; 151(5):860-869.e7. PubMed ID: 27492616
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of glutathione S-transferase polymorphisms and mutagen sensitivity as risk factors for the development of second primary tumors in patients previously diagnosed with early-stage head and neck cancer.
    Minard CG; Spitz MR; Wu X; Hong WK; Etzel CJ
    Cancer; 2006 Jun; 106(12):2636-44. PubMed ID: 16703596
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A cause-specific Cox model for second primary tumors in patients with head and neck cancer: A RONCDOC study.
    Bugter O; van Iwaarden DLP; van Leeuwen N; Nieboer D; Dronkers EAC; Hardillo JAU; Baatenburg de Jong RJ
    Head Neck; 2021 Jun; 43(6):1881-1889. PubMed ID: 33655596
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Occurrence of metachronous second primary cancer in head and neck cancer survivors: A systematic review and meta-analysis of the literature.
    Hoxhaj I; Hysaj O; Vukovic V; Leoncini E; Amore R; Pastorino R; Boccia S
    Eur J Cancer Care (Engl); 2020 Sep; 29(5):e13255. PubMed ID: 32400912
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.